Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
TEVA
TEVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TEVA News
Long-Term Investment Opportunities Amid Market Volatility
3d ago
Fool
Comparing Turnarounds: Pfizer vs. Teva
6d ago
Fool
Druckenmiller Cuts Pharma and Semiconductor Holdings
6d ago
Fool
Druckenmiller Reduces Stakes in Pharma and Semiconductor Stocks
6d ago
NASDAQ.COM
Teva and Blackstone Reach $400 Million Strategic Funding Agreement
6d ago
NASDAQ.COM
Blackstone and Teva Forge $400M Strategic Funding Agreement
6d ago
seekingalpha
Blackstone Life Sciences Invests $400 Million to Support Teva's Duvakitug Development
6d ago
Newsfilter
Teva Pharmaceutical Stock Doubles, Strong Outlook Ahead
Mar 02 2026
Fool
Teva Pharmaceutical's Investment Opportunities and Risks
Feb 28 2026
Fool
Teva Pharmaceuticals Faces Competition and Risks in Drug Development
Feb 28 2026
NASDAQ.COM
Bridger Management Sells Entire Stake in Bath & Body Works Amid Struggles
Feb 25 2026
Fool
Bridger Management Exits BBWI Stake Amid Market Challenges
Feb 25 2026
NASDAQ.COM
Teva's New Drug Application Accepted by FDA for Schizophrenia Treatment
Feb 23 2026
Benzinga
Teva and Medincell's NDA for Long-Acting Olanzapine Accepted by FDA
Feb 21 2026
seekingalpha
Teva and Medincell's NDA for Olanzapine Accepted by FDA
Feb 21 2026
NASDAQ.COM
TEVA's New Drug Application Accepted by FDA for Schizophrenia Treatment
Feb 20 2026
stocktwits
Show More News
